Ecolab Inc. operates in a diverse market offering water, hygiene, and infection prevention solutions. The stock's current standing shows a moderate performance in fundamental evaluations, boasting strong returns but challenged by debt and price metrics. Analysts view it favorably with a consensus leaning towards a buying opportunity.
The fundamental score for Ecolab Inc. reflects a stable performance, with particular strength in returns metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
The historical data provides insight into the consistency and changes in Ecolab Inc.'s performance metrics.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
| 2025-12-22 | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
Analyst targets suggest a potential upward trend with favorable median and consensus price points.
| High | Low | Median | Consensus |
|---|---|---|---|
| $426 | $291 | $303.5 | $318.25 |
The sentiment among analysts is generally positive indicating a buy consensus.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 23 | |
| Hold | 11 | |
| Sell | 1 | |
| Strong Sell | 0 |
Ecolab Inc. exhibits a solid track record in return-based metrics, which bolsters its appeal despite weaknesses in valuation ratios like P/E and P/B. The company's diversified exposure across various industries lends it stability, but leverage remains a concern. Analyst projections lean towards optimism with a consensus urging a buy recommendation. The stock shows moderate growth potential with risks primarily stemming from financial leverage and competitive pressures in the chemicals sector.